Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a serious complication.

The following content is for informational purposes only. This article is not intended to be a substitute for profession ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

Health care, ride sharing, and the emerging world of YouTube entertainers are among industries leading investors have picked ...

The Medicines and Healthcare Products Regulatory Agency (MHRA) has ruled that warnings about the risk should now be added to drugs like Ozempic, Wegovy and Mounjaro.

Ozempic, a medication known for its dual role in treating type 2 diabetes and aiding weight management, has seen a surge in popularity. However, this once-a-week injectable isn't without its risks.

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects that you need to be aware of before giving them a try ...

"Ozempic functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, which not only helps lower blood sugar levels but also plays a significant role in weight management, making it a dual ...

A Novo spokesperson said at the time that the company was now shipping all doses of Ozempic and Wegovy to wholesalers around the U.S., but, as of January, the FDA still has not formally declared ...

The GLP-1s semaglutide and tirzepatide marketed by NVO and LLY as Ozempic/Wegovy and Mounjaro ... year to $11.3B after the U.S. FDA approved the dual GLP-1/GIP receptor agonist for obesity and ...

As concerns around knockoffs of newer GLP-1 drugs like Ozempic and Wegovy take center ... its decision to declare the shortage of Lilly’s dual GIP/GLP-1 agonist tirzepatide resolved.